Diligence memo · auto-generated · as of July 2, 2026
Mb2 Llc
Mb2 Llc looks fair against its niche peers and is dormant on financing cadence.
Businessfiled
Mb2 Llc operates in Pharmaceuticals, based in Carmel.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Mb2 Llc has raised $1.5M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Seed (a $1.0M–$4.0M round).
Largest single filing: $1.5M on 2014-12-11.
Most recent recorded round closed around 2014-12-11.
Valuation (modeled)modeled
Provath models Mb2 Llc at approximately $57M (range $1.1M–$448M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 0.86× the median modeled value of Seed Pharmaceuticals companies in 2013–2015 (51 peers) — value vs value, same stage and era. Within the normal band (86% of peer median) for its niche.
Financing rhythm & timingmixed
Last raise 11.6 yr ago; this sector typically re-raises about every 13 months.
Only one round on record and long silent — often defunct, acquired, or gone quiet.
Comparablesmixed
Capital scale ranks ahead of 24% of Pharmaceuticals peers (1610 compared).
Modeled value ranks above 45% of those peers.
Closest niche peers: Assured Pharma, Inc., Wellesley Pharmaceuticals Llc, Generico, Llc, Aggamin Pharmaceuticals, LLC, Abeona Therapeutics LLC.
Peoplefiled
2 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.